Get started
Immatics N.V.Immatics N.V.Immatics N.V.

Immatics N.V.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

IMTX chart


Full chart

IMTX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪517.80 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
50.99
Basic EPS (TTM)
0.08 USD
Net income (FY)
‪16.46 M‬ USD
Revenue (FY)
‪168.57 M‬ USD
Shares float
‪88.73 M‬
Beta (1Y)
1.42

Employees


Employees (FY)
423
Change (1Y)
+80 +23.32%
Revenue / Employee (1Y)
‪398.50 K‬ USD
Net income / Employee (1Y)
‪38.92 K‬ USD

About Immatics N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Harpreet Singh-Jasuja
Website
immatics.com
Headquarters
Tuebingen
Founded
2020
ISIN
NL0015285941
FIGI
BBG00VTL2H76
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. The company was founded on March 10, 2020, and is headquartered in Tuebingen, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

IMTX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as IMTX.

Frequently Asked Questions


The current price of IMTX is 4.26 USD — it has increased by 3.65% in the past 24 hours. Watch Immatics N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Immatics N.V. stocks are traded under the ticker IMTX.
IMTX stock has risen by 8.12% compared to the previous week, the month change is a −14.97% fall, over the last year Immatics N.V. has showed a −59.16% decrease.
We've gathered analysts' opinions on Immatics N.V. future price: according to them, IMTX price has a max estimate of 20.04 USD and a min estimate of 12.99 USD. Watch IMTX chart and read a more detailed Immatics N.V. stock forecast: see what analysts think of Immatics N.V. and suggest that you do with its stocks.
IMTX reached its all-time high on Mar 17, 2021 with the price of 18.42 USD, and its all-time low was 3.30 USD and was reached on Apr 7, 2025. View more price dynamics on IMTX chart.
See other stocks reaching their highest and lowest prices.
IMTX stock is 5.56% volatile and has beta coefficient of 1.42. Track Immatics N.V. stock price on the chart and check out the list of the most volatile stocks — is Immatics N.V. there?
Today Immatics N.V. has the market capitalization of ‪517.80 M‬, it has increased by 8.17% over the last week.
Yes, you can track Immatics N.V. financials in yearly and quarterly reports right on TradingView.
Immatics N.V. is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
IMTX earnings for the last quarter are 0.48 USD per share, whereas the estimation was −0.31 USD resulting in a 255.84% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about Immatics N.V. earnings.
Immatics N.V. revenue for the last quarter amounts to ‪58.19 M‬ USD, despite the estimated figure of ‪16.74 M‬ USD. In the next quarter, revenue is expected to reach ‪15.98 M‬ USD.
IMTX net income for the last quarter is ‪47.86 M‬ USD, while the quarter before that showed ‪−9.41 M‬ USD of net income which accounts for 608.31% change. Track more Immatics N.V. financial stats to get the full picture.
No, IMTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 423 employees. See our rating of the largest employees — is Immatics N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Immatics N.V. EBITDA is ‪−28.55 M‬ USD, and current EBITDA margin is −16.98%. See more stats in Immatics N.V. financial statements.
Like other stocks, IMTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Immatics N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Immatics N.V. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Immatics N.V. stock shows the sell signal. See more of Immatics N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.